Sergio Borgia

A Multidisciplinary Collaborative Strategy to reduce Fluconazole Resistant Candida parapsilosis Transmission in a Canadian Intensive Care Unit

Rajni Pantelidis, Sergio Borgia, Mahin Baqi, Farzana Mahboob (Rahmaty) et autres

ca (code pays fourni par la source)

Incidence of colonization and infection with carbapenemase-producing Enterobacterales in Toronto and Peel Region, Ontario, 2007–2024

Angel Xinliu Li, Maxime Lefebvre, Zoë Zhong, Huda Almohri et autres

Background: Carbapenemase-producing Enterobacterales (CPE) are an urgent public health threat. Monitoring changes in the epidemiology of CPE is critical to the development of action plans against antimicrobial resistance. Methods: The Toronto Invasive Bacterial Diseases Network (TIBDN) has conducted population-based surveillance for CPE …

ca, ch, us (code pays fourni par la source)

Invasive Group A Streptococcal Disease in Persons Experiencing Postpandemic Homelessness in Canada

Caroline Kassee, Halima Dabaja‐Younis, Lucie Richard, Alyssa Golden et autres

Importance: Both invasive group A streptococcal (iGAS) infections and the number of persons experiencing homelessness (PEH) are increasing. Protection of PEH from the burden of iGAS infections requires understanding of its epidemiology. Objective: To assess whether the resurgence of iGAS infections after …

ca, il (code pays fourni par la source)

Luigi C. Cazzato, Palestina fra Oriente e Occidente. Anglosfera, ferite coloniali, re-esistenza decoloniale (Milano: Meltemi, 2025), pp. 268, ISBN: 979-12-5615-271-1

Sergio Borgia

-

it (code pays fourni par la source)

Luigi C. Cazzato, Palestina fra Oriente e Occidente. Anglosfera, ferite coloniali, re-esistenza decoloniale (Milano: Meltemi, 2025), pp. 268, ISBN: 979-12-5615-271-1

Sergio Borgia

-

it (code pays fourni par la source)

Invasive Group A Streptococcal Infection in Children, 1992-2023

Halima Dabaja-Younis, Christopher Kandel, Karen Green, Jennie Johnstone et autres

Importance: The resurgence of invasive group A streptococcal (iGAS) infections and progress in GAS vaccine development emphasize the importance of understanding current trends in the epidemiology of iGAS. Objective: To describe the epidemiology of pediatric iGAS over a 32-year period. Design, Setting, …

ca (code pays fourni par la source)

P-643. Incidence and Clinical Characteristics of Invasive Group A Streptococcal Infections in Underhoused Adults in Toronto, Canada

Caroline Kassee, Halima Dabaja Younis, Zoë Zhong, Vanessa Allen et autres

Abstract Background Post-pandemic increases of invasive group A streptococcal disease (iGAS) have been reported in many areas of the world; increased risk associated with illicit intravenous (IV) drug use has also been identified. Methods Since 1995, the Toronto Invasive Bacterial Diseases Network …

ca, us (code pays fourni par la source)

P-1290. Invasive group A streptococcal infection in children in Toronto, Canada

Halima Dabaja Younis, Jennie Johnstone, Zoë Zhong, Caroline Kassee et autres

Abstract Background Rising cases of invasive group A streptococcus (iGAS) in children have been reported globally. We assessed the epidemiology of pediatric iGAS over three decades. The annual incidence of invasive GAS infections in children in Toronto and Peel Region during the …

ca, us (code pays fourni par la source)

Resistance‐Associated Substitution Testing Trends and Impact on HCV Treatment Outcomes in Canada: A CanHepC ‐ CANUHC Analysis

Haris Imsirovic, Gisela Macphail, Duncan Webster, Chris Fraser et autres

Resistance-associated substitutions (RASs) are mutations within the hepatitis C (HCV) genome that may influence the likelihood of achieving a sustained virological response (SVR) with direct acting antiviral (DAA) treatment. Clinicians conduct RAS testing to adapt treatment regimens with the intent of improving …

ca (code pays fourni par la source)

Ceftolozane/Tazobactam treatment for patients with hospital-acquired and ventilatory-associated bacterial pneumonia in Canada in 2022–2024: results from the CLEAR registry

George G. Zhanel, Rita Dhami, Melanie Baxter, Maggie Wong et autres

Background We report results from the national CLEAR (Canadian Leadership on Antimicrobial Real-Life Usage) registry on the usage of ceftolozane/tazobactam in Canada from 2022 to 2024.Research design and methods The authors reviewed the final data using the national ethics approved CLEAR study. …

ca, it (code pays fourni par la source)

Mixed‐Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC Analysis

Haris Imsirovic, Gisela Macphail, Brian E. Conway, Chris Fraser et autres

The prevalence of mixed hepatitis C virus (HCV) genotype infection in a representative Canadian HCV cohort is reported and virological response with direct acting antiviral (DAA) treatment was evaluated. 3272 HCV-positive participants were enrolled, of which 2945 (90.0%) initiated DAA therapy. 0.8% …

ca (code pays fourni par la source)

How is ceftobiprole used in Canada: the CLEAR study final results

George G. Zhanel, Justin Kosar, Melanie Baxter, Rita Dhami et autres

BACKGROUND: We report the final results of the clinical usage of ceftobiprole in patients in Canada from data in the national CLEAR (Canadian Le adership on Antimicrobial Real-Life Usage) registry. RESEARCH DESIGN AND METHODS: The authors review the final data using the …

ca, fr, it, us (code pays fourni par la source)